Group revenue

• Teva Pharmaceutical Q4 profit gains as branded drugs aid transition from generics - JERUSALEM, Jan 28 (Reuters) - Teva Pharmaceutical Industries reported strong quarterly results on Wednesday but forecast lower net profit and revenue in 2026 on a more ​than $1 billion expected loss in sales of its generic version of a canc